Cancer Treatment Reviews

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Cancer Treatment Reviews is a journal published by Elsevier BV in United Kingdom. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,330 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1532-1967 · 0305-7372
Country
United Kingdom
Access
Not open access / not declared
Declared publication charge
4,330 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 1974-01-01
Indexing
MEDLINE
APC
4,330 USD
Declared review time (DOAJ)
—
Actual review time (measured)
62 days received→accepted — computed from PubMed (n=98)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4056

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

206

i10-index

2570

From OpenAlex open data (CC0).

Editorial & policy4
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
90%
ORCID iDs in current deposits
43%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
7502030
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cancer Immunotherapy and Biomarkers
  • Human auditory perception and evaluation
  • Lung Cancer Treatments and Mutations
  • Human auditory perception and evaluation
  • Diverse Scientific and Economic Studies
Show all subjects (75)
  • Diverse Scientific and Economic Studies
  • Lung Cancer Treatments and Mutations
  • Educational Robotics and Engineering
  • Educational Robotics and Engineering
  • Lung Cancer Treatments and Mutations
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Colorectal Cancer Treatments and Studies
  • Breast Cancer Treatment Studies
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Cancer Treatment and Pharmacology
  • Cancer therapeutics and mechanisms
  • Bone health and treatments
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Lung Cancer Diagnosis and Treatment
  • HER2/EGFR in Cancer Research
  • Bone health and treatments
  • Bone health and treatments
  • Advanced Breast Cancer Therapies
  • Lung Cancer Research Studies
  • Gastric Cancer Management and Outcomes
  • Cancer therapeutics and mechanisms
  • Cancer therapeutics and mechanisms
  • Head and Neck Cancer Studies
  • Colorectal Cancer Surgical Treatments
  • Neuroendocrine Tumor Research Advances
  • Neuroendocrine Tumor Research Advances
  • Ovarian cancer diagnosis and treatment
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Treatment and Research
  • Cancer survivorship and care
  • Prostate Cancer Treatment and Research
  • Lymphoma Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Advanced Breast Cancer Therapies
  • Advanced Breast Cancer Therapies
  • Cancer Genomics and Diagnostics
  • Radiopharmaceutical Chemistry and Applications
  • Radiopharmaceutical Chemistry and Applications
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • BRCA gene mutations in cancer
  • Immunotherapy and Immune Responses
  • Estrogen and related hormone effects
  • Endometrial and Cervical Cancer Treatments
  • CAR-T cell therapy research
  • CAR-T cell therapy research
  • Cancer Cells and Metastasis
  • Renal cell carcinoma treatment
  • Brain Metastases and Treatment
  • Renal cell carcinoma treatment
  • Brain Metastases and Treatment
  • Renal cell carcinoma treatment
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: